FDA expands Zytiga’s use for late-stage breast cancer
On Dec. 10, the U.S. Food and Drug Administration expanded the approved use of Zytiga (abiraterone acetate) to treat men with metastatic castration-resistant prostate…
Web Exclusives
FDA permits marketing of device to seal lung punctures
On Dec. 19, the U.S. Food and Drug Administration allowed marketing of the Bio-Seal Lung Biopsy Tract Plug System, a device that seals punctures…
NQF endorses more patient safety measures
The National Quality Forum (NQF) Board of Directors has endorsed 12 patient safety measures, including those related to patient falls, pressure ulcers, and healthcare-associated…
Study: Reduced LOS reduces readmission, mortality
A study of 129 Veterans Administration hospitals published in the Annals of Internal Medicine found that hospitals reduced length of stay over 14 years,…
U.S. News names registered nurse one of best jobs for 2013
U.S. News 100 Best Jobs of 2013 puts registered nurse in the number two spot, right after dentist. The report lists the median salary…
Study: Good nurse work environment lowers readmissions
Hospitals with a good versus poor nurse work environment had lower 30-day readmission rates for patients with heart failure, pneumonia, or myocardial infarction, according…
Single-dose IV Zofran pulled from market
On Dec. 4, the U.S. Food and Drug Administration announced that the 32 mg, single IV dose of the anti-nausea drug Zofran (ondansetron hydrochloride)…
FDA approves first flu vaccine using new manufacturing technique
On Nov. 20, the U.S. Food and Drug Administration (FDA) approved Flucelvax, the first seasonal influenza vaccine licensed in the United States produced using…
Study: Health care organizations reduce SSIs by nearly half with Joint Commission project
A 2.5-year project under the direction of the Joint Commission Center for Transforming Healthcare in collaboration with the American College of Surgeons reduced surgical…
FDA approves Xeljanz for rheumatoid arthritis
On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis who…
Study: Surgical checklist reduces 30-day morbidity
Using a surgical safety checklist, including providing comprehensive training on it, significantly decreases 30-day morbidity, according to a study in the Journal of the…
Study: Urinary catheterization high risk for UTI
A review article in December 2012’s Journal of Hospital Infection found that highest population-attributable risk percentage for urinary tract infection (UTI) was associated with…
FDA expands Zytiga’s use for late-stage breast cancer
On Dec. 10, the U.S. Food and Drug Administration expanded the approved use of Zytiga (abiraterone acetate) to treat men with metastatic…
FDA permits marketing of device to seal lung punctures
On Dec. 19, the U.S. Food and Drug Administration allowed marketing of the Bio-Seal Lung Biopsy Tract Plug System, a device that…
NQF endorses more patient safety measures
The National Quality Forum (NQF) Board of Directors has endorsed 12 patient safety measures, including those related to patient falls, pressure ulcers,…
Study: Reduced LOS reduces readmission, mortality
A study of 129 Veterans Administration hospitals published in the Annals of Internal Medicine found that hospitals reduced length of stay over…
U.S. News names registered nurse one of best jobs for 2013
U.S. News 100 Best Jobs of 2013 puts registered nurse in the number two spot, right after dentist. The report lists the…
Study: Good nurse work environment lowers readmissions
Hospitals with a good versus poor nurse work environment had lower 30-day readmission rates for patients with heart failure, pneumonia, or myocardial…
Single-dose IV Zofran pulled from market
On Dec. 4, the U.S. Food and Drug Administration announced that the 32 mg, single IV dose of the anti-nausea drug Zofran…
FDA approves first flu vaccine using new manufacturing technique
On Nov. 20, the U.S. Food and Drug Administration (FDA) approved Flucelvax, the first seasonal influenza vaccine licensed in the United States…
Study: Health care organizations reduce SSIs by nearly half with Joint Commission project
A 2.5-year project under the direction of the Joint Commission Center for Transforming Healthcare in collaboration with the American College of Surgeons…
FDA approves Xeljanz for rheumatoid arthritis
On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid…
Study: Surgical checklist reduces 30-day morbidity
Using a surgical safety checklist, including providing comprehensive training on it, significantly decreases 30-day morbidity, according to a study in the Journal…
Study: Urinary catheterization high risk for UTI
A review article in December 2012’s Journal of Hospital Infection found that highest population-attributable risk percentage for urinary tract infection (UTI) was…